APA (7th ed.) Citation

KR, P., MX, L., OJ, S., J, J., MS, K., H, L., . . . JW, P. (2025). TTP enhances the sensitivity of KRASG12C-mutated lung cancer cells to KRASG12C inhibitors by downregulating SLC7A11 and promoting ferroptosis. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 193, 118772. https://doi.org/10.1016/j.biopha.2025.118772

Chicago Style (17th ed.) Citation

KR, Park, et al. "TTP Enhances the Sensitivity of KRASG12C-mutated Lung Cancer Cells to KRASG12C Inhibitors by Downregulating SLC7A11 and Promoting Ferroptosis." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 193 (2025): 118772. https://doi.org/10.1016/j.biopha.2025.118772.

MLA (9th ed.) Citation

KR, Park, et al. "TTP Enhances the Sensitivity of KRASG12C-mutated Lung Cancer Cells to KRASG12C Inhibitors by Downregulating SLC7A11 and Promoting Ferroptosis." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, vol. 193, 2025, p. 118772, https://doi.org/10.1016/j.biopha.2025.118772.